Variability in pediatric injury patterns by age and ethnic groups in Israel

Bella Savitsky1, Limor Aharonson-Daniel, Adi Giveon

  • 1Israel National Center for Trauma and Emergency Medicine Research, Gerther Institute for Epidemiology and Health Research, Sheba Medical, Tel Hashomer, Israel. bellas@gerther.health.gov.il

Ethnicity & Health
|March 17, 2007
PubMed

Insights

Pediatric injury patterns reveal non-Jewish children face higher risks, particularly from falls and burns. Targeted prevention programs are crucial for vulnerable populations, especially those in low socio-economic status areas.

Area of Science:

  • Pediatric Trauma Research
  • Injury Epidemiology
  • Public Health Interventions

Background:

  • Nearly 10,000 children in Israel are hospitalized annually due to injuries.
  • Understanding injury patterns is key to developing effective prevention strategies.

Purpose of the Study:

  • To identify specific injury patterns within pediatric subgroups.
  • To guide focused prevention efforts on high-risk populations.

Main Methods:

  • Retrospective analysis of the Israel National Trauma Registry (ITR) data (1998-2002).
  • Inclusion of patients aged 0-17 years hospitalized for trauma.
  • Descriptive and inferential statistics (bivariate, multivariate) to compare injury causes and severity across demographic groups, adjusting for socio-economic status (SES).

Main Results:

  • Falls accounted for 51% of injuries, road traffic accidents (RTA) for 23%, and burns for 7%.
  • Non-Jewish children exhibited double the rate of severe injuries and inpatient deaths compared to Jewish children.
  • Non-Jewish children had higher rates of burns, falls from height, and pedestrian RTA injuries, even after adjusting for SES.

Conclusions:

  • Significant variations in injury causes and severity exist among pediatric age and ethnic groups.
  • Non-Jewish children, particularly those in low SES areas, are at elevated risk for severe injuries like falls from height.
  • Intervention and prevention strategies must be tailored to address these specific high-risk groups and injury types.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...